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Institute of Pharmaceutical Education and Research, Gujarat, IndiaA B S T R A C TObjective: To assess the inﬂuence of diabetes on health-related
quality of life (HRQOL) in patients with coronary artery disease
(CAD) and identify predictors of health status at 1-year follow-up
after an acute coronary event.Methods: A prospective cohort study in
patients diagnosed with CAD at a tertiary care hospital from India.
The EuroQol ﬁve-dimensional (EQ-5D) questionnaire was adminis-
tered at 1-year follow-up. Multivariate stepwise liner regression was
used to assess predictors of EQ visual analogue scale (VAS) and EQ-5D
questionnaire utility scores. Respondents reporting problems on the
EQ-5D questionnaire were stratiﬁed by the presence of diabetes at
baseline for comparison. Results: Of 960 (30% diabetic) patients with
CAD enrolled in a main study cohort, 306 (76% males, 21% diabetic)
responded to the HRQOL questionnaire at 1 year. Diabetic patients
reported more difﬁculties/problems than did nondiabetic patients for
EQ-5D questionnaire dimensions (mobility, 12.3% vs. 4.1%, P ¼ 0.03;
usual activities, 56.9% vs. 41.3%, P ¼ 0.03; pain/discomfort, 50.8% vs.
17.8%, P o 0.001; anxiety/depression, 33.8% vs. 14.9%, P o 0.001),ee front matter Copyright & 2014, International S
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ia.except for self-care (12.3% vs. 17.5%, P ¼ 0.35). Mean  SD EQ VAS and
EQ-5D questionnaire utility scores were signiﬁcantly lower for
patients with CAD with diabetes versus those without diabetes (0.75
 0.15 vs. 0.83  0.15, P ¼ 0.0002, and 67.8  8.8 vs. 73.6  5.4, P ¼
0.0001, respectively). Presence of diabetes, use of beta-blockers on
discharge, and treatment strategy signiﬁcantly inﬂuenced the VAS
score, whereas myocardial infarction as ﬁnal diagnosis and the
presence of prior CHF predicted worse EQ-5D questionnaire utility
scores. Conclusions: The poorer HRQOL as assessed by the EQ-5D
questionnaire among patients with CAD who had diabetes highlights
the need of individualized treatment programs to improve outcomes
in this most vulnerable population.
Keywords: coronary artery disease, diabetes, EQ-5D, health-related
quality of life.
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Coronary artery disease (CAD) remains a leading cause of mortal-
ity and morbidity in India and worldwide [1]. During recent
decades, the prevalence of CAD in India has progressively
increased with an estimated adult prevalence of around 11% in
urban settings and 5% in rural areas [2]. CAD imposes a consid-
erable economic loss. For Indian population, the number of
productive years of life lost due to CAD is projected to increase
nearly twofold by 2030 since 2004 [3].
Morbidity and mortality in patients with CAD has improved to
a great extent because of advances in treatment landscape [4].
Conventional treatments for CAD mainly focus on clinical out-
comes, such as survival and extending life. The increased
survival of patients with CAD along with the considerable
physical, emotional, and social consequences for survivors
demand that assessment of health-related quality of life (HRQOL)
is critical to measure clinical outcomes and effectiveness ofhealth care and evaluate the overall well-being of the patients
[5]. There has been a signiﬁcant development in the measure-
ment of quality of life as an indicator of health outcomes in
patients with CAD. The burden of CAD can be signiﬁcant;
reducing frequency and severity of the disease as well as
improving physical functioning remain signiﬁcant determinants
of overall HRQOL in patients with CAD [5].
Diabetes is an established and highly prevalent risk factor for
cardiac morbidity and mortality that worsen prognosis in
patients with CAD [6–8]. Despite optimal management, it is
difﬁcult to improve well-being in diabetic patients and outcomes
for patients with CAD and diabetes remain poor [9]. Limited
studies have examined the factors associated with health status
outcomes after CAD. Little is known about risk factors that
inﬂuence patient-reported outcomes among patients with CAD
from India. In this study, therefore, we aimed to compare HRQOL
in patients with CAD with or without diabetes and identify
predictors of health status at 1 year after an acute CAD event.ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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Study Design
This was a prospective observational study conducted between
January 2011 and January 2012 at a tertiary care hospital from
Jaipur (India). The detailed study design is reported elsewhere
along with the main study cohort results [10].
Inclusion Criteria
Consecutive patients of both genders, aged 18 years or older,
hospitalized at the cardiac intensive care unit of a tertiary care
hospital were considered. Patients who underwent coronary
angiography and diagnosed with myocardial infarction (MI),
unstable angina, or chronic stable angina on ﬁnal diagnosis were
considered to have CAD using standard deﬁnitions [11]. Patients
were identiﬁed as a known case of CAD on the basis of at least
one of the following criteria: history of documented angina/
infarction, electrocardiogram ﬁndings suggestive of silent MI, a
positive treadmill test result or stress echocardiography highly
suggestive of silent MI, history of angina/MI with electrocardio-
gram conﬁrmation, angiographic evidence of CAD, or history of
percutaneous transluminal coronary angioplasty/coronary artery
bypass grafting (CABG). Patients were identiﬁed as diabetics if
they met any of the following criteria: at least one prescription of
antidiabetic drug (as veriﬁed by clinical records), ongoing anti-
diabetic treatment (with or without prescription), or elevated
hemoglobin A1C level (hemoglobin A1C Z 7). Patients with a
history of hypertension and/or on treatment for hypertension
or having at least two elevated blood pressure measurements
were considered hypertensive.
Exclusion Criteria
Patients who did not undergo coronary angiography or diagnosed
with normal coronary artery after coronary angiography and/or
atypical chest pain were excluded.
Procedures
Discharge summaries of patients were reviewed to collect dem-
ographic information, vital signs, and details of other risk factors
for CAD such as presence of diabetes, hypertension, and history
of CAD. Information pertaining to treatment strategies (medical
management, percutaneous transluminal coronary angioplasty,
or CABG) and medications prescribed at discharge was collected.
Patients were followed-up via telephonic interview at 1 year
after an acute CAD event and the EQ-5D questionnaire—a stand-
ardized generic instrument—was administered to assess HRQOL.
The EQ-5D questionnaire comprises the EQ-5D questionnaire
descriptive system and a visual analogue scale—the EQ VAS
[12,13].
The descriptive system comprises ﬁve dimensions: mobility,
self-care, usual activities, pain/discomfort, and anxiety/depres-
sion, with each dimension having three levels of perceived
problems: no problems (level 1), some problems (level 2), and
extreme problems (level 3). For EQ VAS, respondents can indicate
their overall self-rated health state on a scale ranging from 0 to
100, where 0 is equivalent to the “worst imaginable health state”
and 100 is equivalent to the “best imaginable health state.”
Together, the descriptive system and the EQ VAS give valuable
information on the health states of individuals, groups of
patients, and populations. An overall utility score (EQ-5D ques-
tionnaire utility score) was also calculated on the basis of these
dimensions, with the score ranging from 0, representing states as
bad as being death, to a maximum of 1, representing full health.For our study, EQ-5D questionnaire utility scores were derived on
the basis of the UK population because it can be applied to other
populations when country-speciﬁc weights are not available [14],
as in the case of India.Statistical Analyses
All data entries and analyses were performed using Statistical
Package for Social Sciences (SPSS, version 17.0; SPSS, Inc., Chi-
cago, IL). The respondents were stratiﬁed into two groups by
presence of diabetes at baseline. Data obtained from the EQ-5D
questionnaire descriptive system were reported as frequencies
and percentages of respondents having particular levels in
particular dimensions. The frequencies of reported level 3 prob-
lems in this study were very low (o2% of total respondents), so it
was more convenient to dichotomize the EQ-5D questionnaire
levels into “no problems” (level 1) and “any problem” (levels 2 and
3), thereby changing the proﬁle into frequencies of reported
problems [15]. The chi-square test was then applied to test
differences in reported problems between diabetic and nondia-
betic patients with CAD. An independent t test was used to detect
differences between the mean  SD of EQ VAS scores for patients
with CAD with or without diabetes.
EQ-5D questionnaire utility scores for patients with CAD with
or without diabetes were compared using an independent t test.
The multivariate stepwise linear regression models were used to
assess predictors of the EQ VAS and EQ-5D questionnaire utility
scores. The independent variables studied include age, presence
of hypertension, diabetes, congestive heart failure (CHF), sex,
prior MI, ﬁnal diagnosis, ﬁnal treatment, and use of key evidence-
based medication at discharge.
Odds ratios (ORs; 95% conﬁdence intervals, 95% CIs) for
reporting problems in all the ﬁve EQ-5D questionnaire dimen-
sions were calculated using binary regression in patients with or
without diabetes at baseline to quantify the effect of diabetes.
P o 0.05 was considered statistically signiﬁcant, whereas P o
0.001 was considered statistically highly signiﬁcant.Results
Of 960 patients with CAD enrolled in the cohort study, 306 (231
[76%] males; 65 [21%] diabetic patients) patients responded to the
HRQOL questionnaire at 1-year follow-up after an acute
CAD event.Baseline Demographic and Clinical Characteristics
Baseline demographic characteristics, clinical characteristics, and
angiography ﬁndings of all the respondents (stratiﬁed by the
presence of diabetes) are presented in Table 1. Patients who had
diabetes at baseline were older, had 2 times higher proportion of
hypertension, and also a higher proportion of unstable angina on
ﬁnal diagnosis.EQ-5D Questionnaire Assessments
Findings from assessment of each of the ﬁve dimensions of the
EQ-5D questionnaire are given in Table 2.
Diabetic patients were likely to experience more difﬁculties or
problems compared with nondiabetic patients for all the EQ-5D
questionnaire dimensions, except self-care. A signiﬁcantly higher
proportion of diabetic patients (vs. nondiabetic patients) reported
pain or discomfort (50.8% vs. 17.8%) as well as anxiety or
depression (33.8% vs. 14.9%) (P o 0.001 in each case).
Table 1 – Patients’ baseline characteristics and
angiography ﬁndings.
Characteristic Patients with
CAD with
diabetes (n ¼ 65)
Patients with
CAD without
diabetes (n ¼ 241)
Sex, n (%)
Male 47 (72.3) 184 (76.3)
Female 18 (27.7) 57 (23.7)
Age (y)* 59.4  10.4 56  10.6
Blood pressure (mm Hg)*
Systolic 155.8  15.3 140.2  9.7
Diastolic 105.3  16.2 88.4  10.3
Medical history, n (%)
Hypertension 39 (60.0) 73 (30.3)
Known case of
CAD
9 (13.8) 33 (13.7)
Smoking 10 (15.4) 230 (12.5)
Prior CHF 18 (27.7) 64 (26.6)
Final diagnosis, n (%)
Unstable angina 46 (70.8) 147 (61.3)
Myocardial
infarction
18 (27.7) 73 (30.4)
Chronic stable
angina
1 (1.6) 20 (8.3)
Treatment strategy, n (%)
Medical
management
14 (21.5) 77 (32.0)
PTCA 31 (47.7) 119 (49.4)
CABG 20 (30.8) 45 (18.7)
ACS, acute coronary syndrome; CABG, coronary artery bypass
grafting; CAD, coronary artery disease; CHF, congestive heart
failure; PTCA, percutaneous transluminal coronary angioplasty.
*Data are mean  SD.
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At 1-year follow-up, both mean (SD) EQ VAS and EQ-5D ques-
tionnaire utility scores were signiﬁcantly lower for patients with
CAD who had diabetes versus those who did not have diabetes
(67.8  8.8 vs. 73.6  5.4, P ¼ 0.0001, and 0.75  0.15 vs. 0.83  0.15,
P ¼ 0.0002, respectively) (Fig. 1).
Table 3 shows ﬁndings of the multivariate stepwise linear
regression models used to assess the inﬂuence of various risk
factors on 1-year EQ VAS and EQ-5D questionnaire utility scores.
The presence of diabetes showed statistically highly signiﬁ-
cant negative correlation (P o 0.001) with 1-year EQ VAS and EQ-
5D questionnaire utility scores. The use of beta-blockers on
discharge and ﬁnal treatment signiﬁcantly inﬂuenced the EQTable 2 – Proportion of respondents reporting problems
follow-up.
Dimension Patients with CAD with diabetes
(n ¼ 65)
Mobility, n (%) 8 (12.3)
Self-care, n (%) 8 (12.3)
Usual activities, n (%) 37 (56.9)
Pain/discomfort, n (%) 33 (50.8)
Anxiety/depression, n (%) 22 (33.8)
CAD, coronary artery disease; EQ-5D, EuroQol ﬁve-dimensional.
* The chi-square test was applied in calculating P values.VAS score (P o 0.05 in each case), whereas MI as ﬁnal diagnosis
and presence of prior CHF were associated with worse EQ-5D
questionnaire utility scores at 1 year.
Binary regression models demonstrated that the presence of
diabetes at baseline was associated with reporting of more difﬁcul-
ties in patients with CAD at 1-year follow-up for all EQ-5D ques-
tionnaire dimensions, except self-care (mobility: OR 6.5 [95% CI 2.1–
20.0]; usual activities: OR 1.9 [95% CI 1.1–3.2]; pain/discomfort: OR ¼
4.8 [95% CI 2.7–8.6]; anxiety/depression: OR 3.1 [95% CI 1.6–5.9]).Discussion
In recent years, more emphasis has been given to patient-
reported outcome measures such as HRQOL and health utility
within the cardiovascular ﬁeld [16]. HRQOL is deﬁned as patients’
subjective evaluations of inﬂuences of their current health status,
health care, and health-promoting activities on their ability to
achieve and maintain a level of overall functioning that allows
them to pursue valued life goals and that is reﬂected in their
general well-being [5]. Because of the inherent nature of the
disease, patients with CAD are known to perceive poorer quality
of life than do patients without CAD [17,18]. It has been observed
that heterogeneity among individuals’ characteristics such as
varied comorbid conditions and the environment (e.g., different
countries) also inﬂuence the HRQOL [19]. Overall, predictors of
HRQOL can be grouped into physiological/biological factors (e.g.,
prior cardiovascular events, CHF, and diabetes), symptoms (emo-
tional and cognitive variables such as depression and anxiety),
individual characteristics (e.g., age and sex), and environmental
characteristics (e.g., optimization of medical treatment and car-
diac rehabilitation programs) [20].
The goal of the present study was to examine the association
between diabetes and patients’ health status outcomes at 1 year
after an acute event among patients with CAD. Our results
illustrated that patients with CAD and coexisting diabetes had a
signiﬁcantly higher prevalence of hypertension, were more likely
to present with unstable angina, and were more likely to undergo
CABG after hospitalization. It is expected that HRQOL is consid-
erably affected in patients after a cardiac event, especially during
the initial recovery phase. Even though improvement in HRQOL
occurs over time, the persistence of residual distress at 1-year
follow-up remains a challenge for clinicians concerned with full
rehabilitation of the cardiac patient [21,22]. Therefore, the meas-
urement of HRQOL and the assessment of factors affecting the
quality of life may help to improve and sustain the improved
quality of life in patients with CAD.
Diabetes has been established as an important comorbidity in
patients with CAD. Our study results at 1-year follow-up after an
acute coronary event revealed that patients with CAD withon each EQ-5D questionnaire dimensions at 1-y
Patients with CAD without diabetes
(n ¼ 241)
P*
10 (4.1) 0.03
42 (17.5) 0.35
99 (41.3) 0.03
43 (17.8) o0.001
36 (14.9) o0.001
Fig. 1 – (A) Mean EQ VAS scores and (B) mean EQ-5D questionnaire utility scores in patients with CAD with or without diabetes
at baseline. Independent t test was applied for calculating P values. CAD, coronary artery disease; EQ-5D, EuroQol ﬁve-
dimensional; VAS, visual analogue scale.
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activities, comfort, and mental health status than did patients
with CAD who did not have diabetes at baseline. It is known that
patients with diabetes often have a high burden of coronary
atherosclerosis [23], resulting in severe CAD. Hence, it is not
surprising that at 1 year after an acute event, patients with
diabetes were more likely to have a negative inﬂuence on health
status outcomes as observed in our study. Similar ﬁndings have
also been reported by earlier studies [24–26]. The prospective
cohort study by Peterson et al. [24] evaluated the inﬂuence of
diabetes on patients’ health condition 1 year after an acute attack
in patients with acute coronary syndrome (ACS). The ﬁndings of
this study demonstrated that patients with diabetes are consid-
erably more likely to experience angina, cardiac-speciﬁc physical
limitations, and worse HRQOL results 1 year after ACS than do
nondiabetic patients. The results from our study enrich current
scientiﬁc knowledge as well as conﬁrm the negative impact of
diabetes on HRQOL in the Indian population as well afterTable 3 – Predictors of EQ VAS and EQ-5D questionnaire
Parameter Partial regression coefﬁcie
Dependent variable: EQ VAS score*
Diabetes 6.271
Discharge medication, beta-blocker 2.021
Final treatment 1.390
Dependent variable: EQ-5D questionnaire utility score†
Diabetes 0.085
Final diagnosis 0.051
CHF 0.058
Independent parameters studied: age (o45 vs. Z45 y), hypertension (pre
failure or ejection fractionr40%; present vs. absent), sex (male vs. female
and ﬁnal treatment (medical management vs. PTCA or CABG), and use
antihyperlipidemic agent, and ACEI/ARB).
ACEI/ARB, angiotensin-converting enzyme inhibitors or angiotensin rece
artery disease; CHF, congestive heart failure; EQ-5D, EuroQol ﬁve-dimen
coronary angioplasty; VAS, visual analogue scale.
*R ¼ 0.41, R2 ¼ 0.17, adjusted R2 ¼ 0.16, F ¼ 20.06, P o 0.001.
†R ¼ 0.32, R2 ¼ 0.10, adjusted R2 ¼ 0.09, F ¼ 11.57, P o 0.001.discharge.The data from recent studies among patients with
CAD from India have demonstrated opportunities for improving
post-ACS care [27,28]. Similarly, results from our study also
support the need for an early identiﬁcation and aggressive treat-
ment of diabetes in patients with CAD to improve long-term
outcomes. Given the expected adverse outcomes in high-risk
patient population, clinicians should bemore sensitive to potential
inﬂuences of concomitant comorbidities, such as diabetes, on
health outcomes. One of the many possible alternative approaches
to improve postdischarge outcomes among patients with CAD
with diabetes could be using customized strategies to enhance
postdischarge surveillance by patient awareness programs such as
disease management or cardiac rehabilitation [9,29]. This is
imperative from local clinical practice perspective taking into
consideration the fact that the prevalence of diabetes in India
(particularly among patients with CAD) remains considerably high
(studies have reported the prevalence of diabetes at around 40%
[27,28,30], and it is also increasing rapidly).utility scores at 1-y follow-up.
nt SE Standardized partial
regression coefﬁcient
t P
0.865 0.385 7.245 0.000
0.712 0.150 2.836 0.005
0.500 0.148 2.779 0.006
0.020 0.229 4.207 0.000
0.014 0.196 3.496 0.001
0.019 0.171 3.046 0.003
sent vs. absent), diabetes (present vs. absent), CHF (history of heart
), prior MI (present vs. absent), ﬁnal diagnosis (unstable angina or MI)
of key evidence-based medication (antiplatelet agent, beta-blocker,
ptor blockers; CABG, coronary artery bypass grafting; CAD, coronary
sional; MI, myocardial infarction; PTCA, percutaneous transluminal
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association of diabetes with both VAS scores and EQ-5D ques-
tionnaire utility scores in patients with CAD than in their non-
diabetic counterparts. The model assessing predictors of the VAS
score implicates that diabetes along with the appropriate use of
beta-blockers at discharge and treatment strategy (medical man-
agement vs. interventional or surgical) remain crucial for favor-
able health outcomes. There are inconsistencies among ﬁndings
of studies assessing the inﬂuence of diabetes on patients’ health
condition as per treatment strategy after an event. Kim et al. [31]
have demonstrated that patients who undergo an early invasive
strategy (percutaneous coronary intervention) show better life
quality results than do patients treated with the traditional
method, whereas other studies have shown no difference in life
quality between the percutaneous coronary intervention and the
CABG group compared with medical management [32,33]. Simp-
son and Pilote have demonstrated no connection between dia-
betes and life quality in patients with ACS [34]. A recent study by
Kim et al. [35] has proposed the need of comprehensive suppor-
tive care to improve the general health status of ACS survivors
and improve long-term clinical outcomes [35].
In a model predicting factors inﬂuencing EQ-5D questionnaire
utility scores, ﬁnal diagnosis and prior CHF along with diabetes
contributed signiﬁcantly. Because it is not possible to revert
the ﬁnal diagnosis neither change the history of CHF, this
ﬁnding indicates a need of more aggressive treatment plan for
diabetes in patients with CAD after an acute event to improve
outcomes—especially if an individual is a known case of heart
failure. In the absence of country-speciﬁc utility references for the
Indian population, the EQ-5D questionnaire utility scores from our
study may provide a preference-based score for future cost-
effectiveness analyses until the country reference value set is
developed.Limitations
While interpreting the results of this study, certain limitations
have to be taken into consideration. First, because of the obser-
vational study design, no information regarding missing data can
be provided. The diagnosis of diabetes was based on the review of
medical records alone; no information was available about dia-
betes duration or adequacy of control, and patients with undiag-
nosed diabetes may have been misclassiﬁed. The observation on
HRQOL assessments were made at 1-year follow-up as the full
recovery, including the ability to perform daily activities, can be
made within this period after hospitalization. For this reason,
results of this study are preliminary and call for another study
assessing long-term outcomes with a larger patient population.
Last, although most of the known risk factors were considered in
models assessing predictors for EQ VAS and EQ-5D questionnaire
utility scores, the small values of adjusted R2 warrant further
exploratory studies to ascertain other possible risk factors.Conclusions
To our knowledge, this is the ﬁrst study assessing the inﬂuence of
diabetes on HRQOL among patients with CAD from India. The
study conﬁrmed that diabetes remains a critical predictor of
health outcomes among patients with CAD. The poorer HRQOL
in diabetic patients with CAD underline the need of individualized
treatment programs to improve outcomes in this most vulnerable
subgroup of CAD population.Acknowledgment
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